{"id":"comp03","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to the sphingosine-1-phosphate (S1P) receptor, which is involved in the regulation of lymphocyte trafficking and immune response.","oneSentence":"Comp03 is a small molecule that targets the S1P receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:27:43.944Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Relapsing forms of multiple sclerosis"}]},"trialDetails":[{"nctId":"NCT02126670","phase":"PHASE2","title":"ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis","status":"COMPLETED","sponsor":"Promius Pharma, LLC","startDate":"2014-04","conditions":"Actinic Keratosis","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Comp03","genericName":"Comp03","companyName":"Promius Pharma, LLC","companyId":"promius-pharma-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Comp03 is a small molecule that targets the S1P receptor. Used for Relapsing forms of multiple sclerosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}